Tiotropium Drug Profile

What is Tiotropium?

Tiotropium is a long-acting bronchodilator medication belonging to the class of drugs called anticholinergics or antimuscarinic agents. It is primarily prescribed for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and certain cases of asthma. This inhaled medication helps keep airways open for extended periods, making breathing easier for patients with chronic respiratory conditions.

Uses

Tiotropium is approved for several respiratory conditions:

• Chronic Obstructive Pulmonary Disease (COPD): Used as maintenance therapy to reduce exacerbations and improve lung function in patients with COPD, including chronic bronchitis and emphysema
• Asthma (add-on therapy): Prescribed as additional treatment for patients with severe asthma that is not adequately controlled with inhaled corticosteroids and long-acting beta-agonists
• COPD exacerbation prevention: Helps reduce the frequency and severity of COPD flare-ups when used regularly
• Exercise tolerance improvement: May help patients with COPD maintain better physical activity levels by improving breathing capacity

How it works

Tiotropium works by blocking muscarinic receptors in the smooth muscles surrounding the airways in the lungs. When these receptors are blocked, the muscles relax and the airways widen, allowing air to flow more freely in and out of the lungs. The medication provides long-lasting bronchodilation, typically maintaining its effects for 24 hours after inhalation, which allows for once-daily dosing in most cases.

Side effects

Common side effects:

Submit Your Paper

• Dry mouth
• Constipation
• Upper respiratory tract infection
• Sore throat
• Cough
• Headache
• Dizziness
• Urinary tract infection

Serious side effects requiring immediate medical attention:

• Severe allergic reactions (swelling of face, lips, tongue, or throat)
• Sudden worsening of breathing problems or bronchospasm
• Eye pain, blurred vision, or seeing halos around lights
• Difficulty urinating or urinary retention
• Fast or irregular heartbeat

Warnings and precautions

• Narrow-angle glaucoma: Patients with this condition should avoid tiotropium as it may worsen eye pressure and vision problems
• Prostate enlargement: Men with benign prostatic hyperplasia may experience difficulty urinating and should use this medication with caution
• Kidney impairment: Patients with moderate to severe kidney disease may need dosage adjustments, as the drug is primarily eliminated through the kidneys
• Pregnancy and breastfeeding: Limited data available; should only be used when potential benefits outweigh risks, and healthcare providers should carefully evaluate use during pregnancy
• Not for acute symptoms: Tiotropium is not intended for immediate relief of breathing problems and should not replace rescue inhalers

Interactions

• Other anticholinergic medications: Concurrent use may increase the risk of anticholinergic side effects such as dry mouth, constipation, and urinary retention
• Ipratropium bromide: Avoid combining with other short-acting anticholinergic bronchodilators due to overlapping mechanisms and increased side effect risk
• Tricyclic antidepressants: May enhance anticholinergic effects and increase risk of dry mouth and constipation
• Antihistamines: First-generation antihistamines may potentiate anticholinergic side effects
• Bladder medications: Drugs for overactive bladder (oxybutynin, tolterodine) may increase urinary retention risk
• Parkinson’s medications: Some antiparkinson drugs have anticholinergic properties that may interact additively
• Muscle relaxants: Certain muscle relaxants may enhance anticholinergic effects
• Beta-blockers: While not contraindicated, non-selective beta-blockers may counteract bronchodilator effects

Check interactions with the GMJ Interaction Checker

Dosage

The typical adult dosage of tiotropium varies depending on the delivery device:

• HandiHaler (capsules for inhalation): 18 mcg once daily
• Respimat inhaler: 2.5 mcg (two puffs of 1.25 mcg each) once daily for COPD; 5 mcg (two puffs of 2.5 mcg each) once daily for asthma

Dosage should always be determined and monitored by a healthcare provider based on individual patient needs, kidney function, and response to treatment. Patients should be instructed on proper inhaler technique to ensure optimal medication delivery to the lungs.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).